• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX FX 15 HOLLOW FIBER OXYGENATOR AF; BLOOD GAS OXYGENATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX FX 15 HOLLOW FIBER OXYGENATOR AF; BLOOD GAS OXYGENATOR Back to Search Results
Catalog Number CX-XRY17602
Device Problem Decrease in Pressure (1490)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 05/18/2015
Event Type  malfunction  
Event Description
The user facility reported insufficient gas exchange in the capiox device during a procedure.Follow up communication with the user facility reported the following information: the actual sample was used on the patient who was put on the pcps circulation; around 2 hours after the initiation of the circulation, pao2 was noted to have decreased; fio2 was increased to 100% and the gas flow rate up to 12l/min.; and the patient was weaned off bypass.
 
Manufacturer Narrative
The actual device was returned to the manufacturing facility for evaluation.Visual inspection of the actual sample upon receipt found no obvious abnormalities which could have caused or contributed to the reported insufficient gas transfer performance.The actual device was sterilized with glutaraldehyde solution and the housing component was removed for further inspection of the inside of the oxygenator module.Visual inspection did not find any thrombus formation either on the filter or the inside of the fiber layer.After removing the fiber layer, the heat exchanger module was inspected under magnification.There was no formation of thrombus on the outer cylinder of the heat exchanger module.The fiber that had been removed from the oxygenator module was inspected under magnification, and it was confirmed there was no presence of thrombus.A review of the device history record of the involved product/lot# combination confirmed there were no indications of production related anomalies.A search of the complaint file found no other report with the involved product/lot# combination.The provided perfusion record was reviewed.The patient was (b)(6).Pao2 was always kept above 300mmhg all the way through the case.Although an exact cause for the reported issue cannot be determined based on the available information and device evaluation, there is no evidence that this event was related to a device defect or malfunction.The actual sample did not reveal any anomalies that would have contributed to the reported issue.In addition, the perfusion record showed no indications of a decrease in the pao2.The device labeling does address the potential for such an occurrence in the instruction for use (ifu) with the statement such as the following: measure blood gases and make necessary adjustments.Control pao2 by changing concentration of oxygen in ventilating gas using gas blender.To decrease pao2, decrease fio2 and to increase pao2, increase fio2.All available information has been placed on file in quality management for appropriate tracking, trending and follow up.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX FX 15 HOLLOW FIBER OXYGENATOR AF
Type of Device
BLOOD GAS OXYGENATOR
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA   418
Manufacturer Contact
kathleen little
950 elkton blvd.
elkton, MD 21921
8002837866
MDR Report Key4840410
MDR Text Key21552446
Report Number9681834-2015-00106
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K071494
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Other
Type of Report Initial
Report Date 05/19/2015,06/12/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/12/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2016
Device Catalogue NumberCX-XRY17602
Device Lot Number150123
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/21/2015
Is the Reporter a Health Professional? No
Distributor Facility Aware Date05/19/2015
Device Age4 MO
Event Location Hospital
Date Report to Manufacturer05/19/2015
Date Manufacturer Received05/19/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/23/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age65 YR
Patient Weight65
-
-